Investors / Switzerland / VP Venture Partners
VP Venture Partners
Venture capital · Zurich, Switzerland · Europe
VP Venture Partners is a private Zurich-based venture capital firm that supports early-stage life science companies in Europe. It builds, coaches, and finances startups from early stage to exit, and provides hands-on support including board and interim C-level positions.
Invests inHealthcare & Biotech
In its own wordslife sciencesmedical devicesdigital healthdiagnosticsdeep techhealthcare
Your fit with VP Venture Partners
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsVP Venture Partners lists 13 checked portfolio companies on its own site and is named in 3 funding rounds, 2 of them as lead. Its most frequent entry is Seed, 100% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 38% of its companies are based in Switzerland. It invests most often alongside BlueOcean Ventures, Caesar Ventures and Creative Destruction Lab.
Counts come from funding rounds that name VP Venture Partners, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Round figures show recent activity, not VP Venture Partners' whole history. Rounds on record name 3 companies; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 100% |
| Series A | 0% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 0 | 0 |
| '26 | 3 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 76th | 3 rounds in 12 months |
| Early stage | 100th | 100% of entries at pre-seed or seed |
| Evidence | 94th | 23% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 84th | 6 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| BlueOcean Ventures | 1 |
| Caesar Ventures | 1 |
| Creative Destruction Lab | 1 |
| Debiopharm Innovation Fund | 1 |
| EFI Lake Geneva Ventures | 1 |
| High-Tech Gründerfonds | 1 |
| Inkef | 1 |
| Invest-NL | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers13100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with BlueOcean Ventures
Compare VP Venture Partners head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with VP Venture Partners| Date | Company | Stage |
|---|---|---|
| 15 Jun 2026 | Seed Led | |
| 6 May 2026 | Seed Led | |
| 17 Mar 2026 | Seed |
Round details for VP Venture Partners
Amounts, full round histories and every co-investor in VP Venture Partners' rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| At aTENSION, we are redefining the future of hypertension care by setting new standards in precision diagnostics and personalized therapies. | Healthcare & Biotech | Portfolio page | ||
| BC Platforms brings together hard-to-access global data, AI-native technology, advanced analytics, governed access and federation, and scientific and technical expertise in one integrated evidence-generation solution. | Healthcare & Biotech | Portfolio page | ||
| CollimateHealth develops microbeam radiation technology for cancer treatment. | Healthcare & Biotech | Jun 2026Seed | Page + round | |
| Diamens develops a test to detect women's health conditions, such as endometriosis, using menstrual blood | Healthcare & Biotech | Mar 2026Seed | Page + round | |
| eMurmur Health analyzes heart and lung sound recordings using artificial intelligence to provide healthcare professionals with objective insights | Healthcare & Biotech | Portfolio page | ||
| Hemotune develops a magnetic nanoparticle platform for targeted magnetic separation in medicine and biomanufacturing. | Healthcare & Biotech | Portfolio page | ||
| Luciole Medical develops and produces medical devices for brain health monitoring | Healthcare & Biotech | Portfolio page | ||
| Moonlight AI develops an AI diagnostics platform that detects genomic biomarkers and diagnoses complex diseases from routine imaging of hematology and cytology smears | Healthcare & Biotech | May 2026Seed | Page + round | |
| The company develops therapies, including spinal cord stimulation and brain-computer interface technology, for people with spinal cord injury and Parkinson's disease. | Healthcare & Biotech | Portfolio page | ||
| Recovery Cat develops individual treatment paths together with patients and practitioners using digital therapy support. | Healthcare & Biotech | Portfolio page | ||
| Resilience builds digital solutions that harness the power of health data to enable more precise care in oncology, psychiatry, and gastroenterology | Healthcare & Biotech | Portfolio page | ||
| Simulatory turns expert surgeons' skill into lifelike training for people and safety intelligence for robots, so every procedure is performed with more skill and more confidence. | Healthcare & Biotech | Portfolio page | ||
| Xeltis develops artificial vessels and valves that are gradually replaced by patients' own living healthy tissue. | Healthcare & Biotech | Portfolio page |
About this data
site last read 7 Nov 2026- Site
- vpventurepartners.com
- Last read
- 7 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 17 Mar 2026
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get VP Venture Partners' profile as data
Pull VP Venture Partners' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/vpventurepartners.com
# also
GET /v1/firms/vpventurepartners.com/portfolio
GET /v1/firms/vpventurepartners.com/coinvestors
GET /v1/firms/vpventurepartners.com/news